Raj, A.; Patel, V.; Dang, M.; Kayastha, A.; Kagzi, Y.; Pitchan Velammal, P.N.K.; Agrawal, N.; Sharma, K.; Hansen, N.; Wen, S.;
et al. Emerging Role of BTK Inhibitors in Multiple Sclerosis: From Immunobiology to Clinical Translation. Brain Sci. 2026, 16, 634.
https://doi.org/10.3390/brainsci16060634
AMA Style
Raj A, Patel V, Dang M, Kayastha A, Kagzi Y, Pitchan Velammal PNK, Agrawal N, Sharma K, Hansen N, Wen S,
et al. Emerging Role of BTK Inhibitors in Multiple Sclerosis: From Immunobiology to Clinical Translation. Brain Sciences. 2026; 16(6):634.
https://doi.org/10.3390/brainsci16060634
Chicago/Turabian Style
Raj, Aashray, Vansh Patel, Mehak Dang, Aken Kayastha, Yusuf Kagzi, Praveen Nandha Kumar Pitchan Velammal, Nidhi Agrawal, Kushagra Sharma, Nicholas Hansen, Sijin Wen,
and et al. 2026. "Emerging Role of BTK Inhibitors in Multiple Sclerosis: From Immunobiology to Clinical Translation" Brain Sciences 16, no. 6: 634.
https://doi.org/10.3390/brainsci16060634
APA Style
Raj, A., Patel, V., Dang, M., Kayastha, A., Kagzi, Y., Pitchan Velammal, P. N. K., Agrawal, N., Sharma, K., Hansen, N., Wen, S., Jaiswal, S., & Sriwastava, S.
(2026). Emerging Role of BTK Inhibitors in Multiple Sclerosis: From Immunobiology to Clinical Translation. Brain Sciences, 16(6), 634.
https://doi.org/10.3390/brainsci16060634